These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 28862757)

  • 21. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
    Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
    Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW; Zhou J; Zhang CH; Liu XS
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.
    Zhang N; Xie Y; Li B; Ning Z; Wang A; Cui X
    Int J Clin Exp Pathol; 2015; 8(3):2771-8. PubMed ID: 26045783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
    Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
    Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.
    Wei L; Liu Q; Huang Y; Liu Z; Zhao R; Li B; Zhang J; Sun C; Gao B; Ding X; Yu X; He J; Sun A; Qin Y
    Int J Biochem Cell Biol; 2020 Mar; 120():105685. PubMed ID: 31917284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated
    Xiang X; Fu Y; Zhao K; Miao R; Zhang X; Ma X; Liu C; Zhang N; Qu K
    Theranostics; 2021; 11(10):4929-4944. PubMed ID: 33754036
    [No Abstract]   [Full Text] [Related]  

  • 29. TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential.
    Mishima M; Takai A; Takeda H; Iguchi E; Nakano S; Fujii Y; Ueno M; Ito T; Teramura M; Eso Y; Shimizu T; Maruno T; Hidema S; Nishimori K; Marusawa H; Hatano E; Seno H
    J Pathol; 2024 Nov; 264(3):318-331. PubMed ID: 39329419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
    Ko E; Seo HW; Jung ES; Kim BH; Jung G
    Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X; Qin J; Lu S
    Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
    Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
    Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
    Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
    Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
    Li R; Okada H; Yamashita T; Nio K; Chen H; Li Y; Shimakami T; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.
    Chand V; Pandey A; Kopanja D; Guzman G; Raychaudhuri P
    Mol Cancer Res; 2019 May; 17(5):1063-1074. PubMed ID: 30814128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.